Fungal Infections in the Compromised Patient
John Wiley & Sons Ltd (Verlag)
978-0-471-92841-6 (ISBN)
- Titel ist leider vergriffen;
keine Neuauflage - Artikel merken
Opportunistic fungal infections, such as cryptococcosis and mucosal forms of candidosis, have since emerged as major problems in AIDS patients. Classical infections, such as histoplasmosis and the dermatophytoses, have appeared in modified forms in these individuals. Much else besides has changed - the use of more intensive chemotherapeutic regimens has contributed to a rising incidence of serious fungal infection among cancer patients. On the other hand, more sophisticated management of immunosuppression has resulted in fewer infectious complications among organ transplant recipients. Improved methods of diagnosis and new antifungal drugs have appeared, but an ever-increasing number of new fungal pathogens have been isolated from immunosuppressed patients. The aim of this monograph is to bring together in a single account the clinical, mycological, immunological and therapeutic aspects of the different fungal infections that occur in the compromised patient. The opening chapter outlines the mechanisms underlying the pathogenesis of fungal infection, followed by a chapter focusing on the factors that predispose the compromised patient to fungal infection.
This chapter also gathers together certain aspects of management, such as empirical treatment and prevention of infection. Individual chapters deal in turn with each of the more frequent infections that occur in the compromised patient and an additional chapter brings together information on a number of the less common infections that have been reported. There is a new chapter describing the manifestations of the various superficial infections in the compromised host. The final chapter reviews the serological methods used in the diagnosis of fungal infection.
Pathogenesis of fungal infection in the non-compromised host, M.D. Richardson and G.S. Shankland; introduction to the management of fungal infection in the compromised patient, D.W. Warnock; clinical manifestations and management of candidosis in the compromised patient, B. Dupont; clinical manifestations and management of cryptococcosis in the compromised patient, R.J. Hay; clinical manifestations and management of aspergillosis in the compromised patient, J. Cohen; clinical manifestations and management of mucormycosis in the compromised patient, K.J. Skaham et al; clinical manifestations and management of histoplasmosis in the compromised patient, S.F. Davies and G.A. Sarosi; clinical manifestations and management of coccidioidomycosis in the compromised patient, D.A. Stevens; clinical manifestations and management of blastomycosis in the compromised patient, S.F. Davies and G.A. Sarosi; clinical manifestations and management of superficial fungal infection in the compromised patient, R.J. Hay; clinical manifestations and management of hyalohyphomycosis, phaeohyphomycosis and other uncommon forms of fungal infections in the compromised patient, D.W. Warnock and E.M. Johnson; serological tests in the diagnosis and prognosis of fungal infection in the compromised patient, V. Hopwood and E.G.V. Evans.
| Erscheint lt. Verlag | 26.12.1990 |
|---|---|
| Zusatzinfo | 14 half-tones, 31 tables, index |
| Verlagsort | Chichester |
| Sprache | englisch |
| Maße | 34 x 55 mm |
| Gewicht | 705 g |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Dermatologie |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Mikrobiologie / Infektologie / Reisemedizin | |
| ISBN-10 | 0-471-92841-0 / 0471928410 |
| ISBN-13 | 978-0-471-92841-6 / 9780471928416 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
